Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic variants in xenobiotic detoxification enzymes, antioxidant defenses and hormonal pathways as biomarkers of susceptibility to prostate cancer.

The Science of the total environment - 15 Aug 2020

Martinez-Gonzalez L J, Antúnez-Rodríguez A, Vazquez-Alonso F, Hernandez A F, Alvarez-Cubero M J

Abstract excerpt

Cancer is considered a complex disease that in many cases results from the interaction between chemical exposures, either from environmental or dietary sources, and genetic polymorphisms of xenobiotic-metabolizing enzymes (XME) or antioxidant enzymatic defenses. This study explored associations and interactions between genetic and environmental risk factors on the risk of prostate cancer (PCa) in 323 subjects...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antioxidants
Share to Arylamine N-Acetyltransferase

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Aryldialkylphosphatase

Share to Biomarkers

Share to Inactivation, Metabolic

Share to Oxidative Stress

Share to Prostatic Neoplasms

Share to Risk Factors

Source

Identifiers

PMID: 32388358
DOI: 10.1016/j.scitotenv.2020.138314

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic variants in xenobiotic detoxification enzymes, antioxidant defenses and hormonal pathways as biomarkers of susceptibility to prostate cancer.PMID 32388358Read ↗

Genetic variants of antioxidant and xenobiotic metabolizing enzymes and their association with prostate cancer: A meta-analysis and functional in silico analysis.Semantic proximity Read ↗

Xenobiotic-metabolizing gene variants, pesticide use, and the risk of prostate cancer.Semantic proximity Read ↗

Polymorphisms in oxidative stress pathway genes and prostate cancer risk.Semantic proximity Read ↗

Genetic susceptibility loci, pesticide exposure and prostate cancer risk.Semantic proximity Read ↗

The Association of Polymorphisms in Genes Encoding Antioxidant Enzymes GPX1 (rs1050450), SOD2 (rs4880) and Transcriptional Factor Nrf2 (rs6721961) with the Risk and Development of Prostate Cancer.Semantic proximity Read ↗

Factors associated with oxidative stress and cancer risk in the Breast and Prostate Cancer Cohort Consortium.Semantic proximity Read ↗

Genetic susceptibility of CYP1A1 gene and risk of pesticide exposure in prostate cancer.Semantic proximity Read ↗

Relationship among metabolizing genes, smoking and alcohol used as modifier factors on prostate cancer risk: exploring some gene-gene and gene-environment interactions.Semantic proximity Read ↗

Polymorphisms in drug-metabolizing genes and urinary bladder cancer susceptibility and prognosis: Possible impacts and future management.Semantic proximity Read ↗

Heterocyclic aromatic amine [HCA] intake and prostate cancer risk: effect modification by genetic variants.Semantic proximity Read ↗

Oxidative stress-related genetic variants, pro- and antioxidant intake and status, and advanced prostate cancer risk.Semantic proximity Read ↗

Allelic variants in xenobiotic metabolism genes predict susceptibility and worse prognosis of urothelial bladder cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.